First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 10, 2011, Pages 4912-4914

  Bador, Julien ^a   Amoureux, Lucie ^a   Duez, Jean Marie ^a   Drabowicz, Anthony ^a   Siebor, Eliane ^a   Llanes, Catherine ^b   Neuwirth, Catherine ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFALOTIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANATE POTASSIUM PLUS TICARCILLIN; COLISTIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; TIGECYCLINE; TOBRAMYCIN;

ACHROMOBACTER XYLOSOXIDANS; ARTICLE; AXYB GENE; BACTERIAL GENE; BACTERIAL STRAIN; CELL DIFFERENTIATION; CELL DIVISION; CONTROLLED STUDY; EFFUSION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PUMP; RESISTANCE NODULATION CELL DIVISION;

ACHROMOBACTER DENITRIFICANS; AZTREONAM; BACTERIAL OUTER MEMBRANE PROTEINS; CEPHALOSPORINS; CHLORAMPHENICOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NALIDIXIC ACID;

EID: 80052824530     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00341-11     Document Type: Article

References (25)

1. Aisenberg, G., K. V. Rolston, and A. Safdar. 2004. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003). Cancer 101:2134-2140.
2. Almuzara, M., et al. 2010. In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods. Int. J. Antimicrob. Agents 35:68-71.
3. Alonso, A., and J. L. Martinez. 2000. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 44:3079-3086.
4. Burns, J. L., C. D. Wadsworth, J. J. Barry, and C. P. Goodall. 1996. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob. Agents Chemother. 40:307-313.
5. Chan, Y. Y., T. M. Tan, Y. M. Ong, and K. L. Chua. 2004. BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 48:1128-1135.
6. De Baets, F., P. Schelstraete, S. Van Daele, F. Haerynck, and M. Vaneechoutte. 2007. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros. 6:75-78.
7. Doi, Y., L. Poirel, D. L. Paterson, and P. Nordmann. 2008. Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans. Antimicrob. Agents Chemother. 52:1952-1956.
8. Glupczynski, Y., W. Hansen, J. Freney, and E. Yourassowsky. 1988. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob. Agents Chemother. 32:276-278.
9. Hansen, C. R., et al. 2010. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 9:51-58.
10. Hearn, E. M., J. J. Dennis, M. R. Gray, and J. M. Foght. 2003. Identification and characterization of the emhABC efflux system for polycyclic aromatic hydrocarbons in Pseudomonas fluorescens cLP6a. J. Bacteriol. 185:6233-6240.
11. Iyobe, S., et al. 2002. Detection of a variant metallo-beta-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an Alcaligenes xylosoxidans strain. Antimicrob. Agents Chemother. 46:2014-2016.
12. Lister, P. D., D. J. Wolter, and N. D. Hanson. 2009. Antibacterial- resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22:582-610.
13. Masuda, N., et al. 2000. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:3322-3327.
14. Moore, R. A., D. DeShazer, S. Reckseidler, A. Weissman, and D. E. Woods. 1999. Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 43:465-470.
15. Neuwirth, C., et al. 2006. VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France. Emerg. Infect. Dis. 12:1737-1739.
16. Pilhofer, M., et al. 2007. Characterization of bacterial operons consisting of two tubulins and a kinesin-like gene by the novel two-step gene walking method. Nucleic Acids Res. 35:e135.
17. Poole, K. 2001. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol. 3:255-264.
18. Poole, K., K. Krebes, C. McNally, and S. Neshat. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372. (Pubitemid 23339316)
19. Poole, K., and R. Srikumar. 2001. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top. Med. Chem. 1:59-71.
20. Razvi, S., et al. 2009. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest 136:1554-1560.
21. Riccio, M. L., L. Pallecchi, R. Fontana, and G. M. Rossolini. 2001. In70 of plasmid pAX22, a blaVIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob. Agents Chemother. 45:1249-1253.
22. Saiman, L., et al. 2001. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J. Clin. Microbiol. 39:3942-3945.
23. Shibata, N., et al. 2003. PCR typing of genetic determinants for metallobeta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol. 41:5407-5413.
24. Sofianou, D., A. Markogiannakis, E. Metzidie, S. Pournaras, and A. Tsakris. 2005. VIM-2 metallo-beta-lactamase in Achromobacter xylosoxidans in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 24:854-855.
25. Tena, D., A. Gonzalez-Praetorius, M. Perez-Balsalobre, O. Sancho, and J. Bisquert. 2008. Urinary tract infection due to Achromobacter xylosoxidans: report of 9 cases. Scand. J. Infect. Dis. 40:84-87.